Interleukin-6 Signaling Drives Fibrosis in Unresolved Inflammation
2014 · Immunity · 359 citations
https://doi.org/10.1016/j.immuni.2013.10.022
M
Mark Lambie
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
134
Papers
4.2K
Citations
29
h-index
59
i10-index
Mark Lambie is an academic researcher from University Hospitals of North Midlands NHS Trust. The author has contributed to research in topics: Dialysis and Renal Disease Management & Central Venous Catheters and Hemodialysis & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 29, co-authored 114 publications.
ORCID: 0000-0002-6285-5368Papers by this author
worksEstablishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) Consensus Workshop
2020 · American Journal of Kidney Diseases · 177 citations
https://doi.org/10.1053/j.ajkd.2019.09.017
Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
2024 · The Lancet · 61 citations
https://doi.org/10.1016/s0140-6736(23)02843-x
Catheter Event Rates in Medical Compared to Surgical Peritoneal Dialysis Catheter Insertion
2023 · Kidney International Reports · 16 citations
https://doi.org/10.1016/j.ekir.2023.09.015
Poor glycemic control and its predictors among people living with diabetes in low- and middle-income countries: a systematic review and meta-analysis
2025 · BMC Public Health · 9 citations
https://doi.org/10.1186/s12889-025-21828-y
Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
2024 · Kidney International Reports · 7 citations
https://doi.org/10.1016/j.ekir.2024.04.062
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat